(Q39535880)

English

Comparison of two investigative assays for the complexed prostate-specific antigen in total prostate-specific antigen between 4.1 and 10.0 ng/mL.

scientific article published on May 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Comparison of two investigative assays for the complexed prostate-specific antigen in total prostate-specific antigen between 4.1 and 10.0 ng/mL. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

author name string

Okegawa T

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Noda H

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Nutahara K

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Higashihara E

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

0 references

publication date

1 May 2000

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

700-704

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900589-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900589-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900589-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900589-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900589-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen predominantly forms a complex with alpha 1-antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900589-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900589-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900589-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Complexed prostate-specific antigen and its volume indexes in the detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900589-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Advantages of replacing the total PSA assay with the assay for PSA-alpha 1-antichymotrypsin complex for the screening and management of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900589-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of complexed PSA improves specificity for early detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900589-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900589-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900589-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(99)00589-0

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39535880&oldid=1525223349"